130 related articles for article (PubMed ID: 17595763)
1. Diabetes alters expression of p53 and c-myc in different stages of oral oncogenesis.
Vairaktaris E; Kalokerinos G; Goutzanis L; Spyridonidou S; Vassiliou S; Derka S; Nkenke E; Yapijakis C; Vylliotis A; Lazaris A; Patsouris E
Anticancer Res; 2007; 27(3B):1465-73. PubMed ID: 17595763
[TBL] [Abstract][Full Text] [Related]
2. Diabetes increases both N-ras and ets-1 expression during rat oral oncogenesis resulting in enhanced cell proliferation and metastatic potential.
Vairaktaris E; Goutzanis L; Kalokerinos G; Yannopoulos A; Yapijakis C; Vassiliou S; Spyridonidou S; Vylliotis A; Nkenke E; Lazaris AC; Tesseromatis C; Patsouris E
In Vivo; 2007; 21(4):615-21. PubMed ID: 17708355
[TBL] [Abstract][Full Text] [Related]
3. Diabetes does not influence oral oncogenesis through fibroblast growth factor receptors.
Vairaktaris E; Goutzanis L; Nkenke E; Spyridonidou S; Vassiliou S; Derka S; Vylliotis A; Yapijakis C; Lazaris A; Strantzias P; Kalimeras E; Patsouris E
In Vivo; 2007; 21(4):623-8. PubMed ID: 17708356
[TBL] [Abstract][Full Text] [Related]
4. Diabetes and oral oncogenesis.
Vairaktaris E; Spyridonidou S; Goutzanis L; Vylliotis A; Lazaris A; Donta I; Perrea D; Yapijakis C; Patsouris E
Anticancer Res; 2007; 27(6B):4185-93. PubMed ID: 18225590
[TBL] [Abstract][Full Text] [Related]
5. Expression of cell cycle regulator p16 is not affected by diabetes during oral oncogenesis.
Vairaktaris E; Goutzanis L; Nkenke E; Spyridonidou S; Vassiliou S; Derka S; Vylliotis A; Yapijakis C; Lazaris A; Patsouris E
In Vivo; 2007; 21(5):745-50. PubMed ID: 18019407
[TBL] [Abstract][Full Text] [Related]
6. The co-expression of c-myc and p53 increases and reaches a plateau early in oral oncogenesis.
Papakosta V; Vairaktaris E; Vylliotis A; Derka S; Nkenke E; Vassiliou S; Lazaris A; Mourouzis C; Rallis G; Spyridonidou S; Anagnostopoulou S; Perrea D; Donta I; Yapijakis C; Patsouris E
Anticancer Res; 2006; 26(4B):2957-62. PubMed ID: 16886620
[TBL] [Abstract][Full Text] [Related]
7. Diabetes enhances cell proliferation but not Bax/Bcl-2-mediated apoptosis during oral oncogenesis.
Vairaktaris E; Kalokerinos G; Goutzanis L; Yapijakis C; Derka S; Vassiliou S; Spyridonidou S; Vylliotis A; Nkenke E; Lazaris A; Patsouris E
Int J Oral Maxillofac Surg; 2008 Jan; 37(1):60-5. PubMed ID: 17825529
[TBL] [Abstract][Full Text] [Related]
8. The hamster model of sequential oral oncogenesis.
Vairaktaris E; Spyridonidou S; Papakosta V; Vylliotis A; Lazaris A; Perrea D; Yapijakis C; Patsouris E
Oral Oncol; 2008 Apr; 44(4):315-24. PubMed ID: 18061531
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of oral cancer in diabetic animals is not associated with c-jun activation pathway.
Vairaktaris E; Goutzanis L; Kalokerinos G; Vassiliou S; Spyridonidou S; Avgoustidis D; Strantzias P; Lazaris A; Papageorgiou G; Ragos V; Yapijakis C; Patsouris E
J Craniomaxillofac Surg; 2007 Dec; 35(8):382-7. PubMed ID: 18023197
[TBL] [Abstract][Full Text] [Related]
11. [Bax protein expression in the carcinogenesis of human oral mucosa].
Zeng X; Chen Q; Li B; Tan N
Hua Xi Kou Qiang Yi Xue Za Zhi; 2000 Apr; 18(2):88-90. PubMed ID: 12539337
[TBL] [Abstract][Full Text] [Related]
12. Loss of tumour suppressor p16 expression in initial stages of oral oncogenesis.
Vairaktaris E; Yapijakis C; Psyrri A; Spyridonidou S; Yannopoulos A; Lazaris A; Vassiliou S; Ferekidis E; Vylliotis A; Nkenke E; Patsouris E
Anticancer Res; 2007; 27(2):979-84. PubMed ID: 17465230
[TBL] [Abstract][Full Text] [Related]
13. Cell proliferation and apoptosis culminate in early stages of oral oncogenesis.
Derka S; Vairaktaris E; Papakosta V; Vassiliou S; Acil Y; Vylliotis A; Spyridonidou S; Lazaris AC; Mourouzis C; Kokkori A; Moulavasili P; Perrea D; Donta I; Yapijakis C; Patsouris E
Oral Oncol; 2006 May; 42(5):540-50. PubMed ID: 16464633
[TBL] [Abstract][Full Text] [Related]
14. Potential involvement of MYC- and p53-related pathways in tumorigenesis in human oral squamous cell carcinoma revealed by proteomic analysis.
Koehn J; Krapfenbauer K; Huber S; Stein E; Sutter W; Watzinger F; Erovic BM; Thurnher D; Schindler T; Fountoulakis M; Turhani D
J Proteome Res; 2008 Sep; 7(9):3818-29. PubMed ID: 18700792
[TBL] [Abstract][Full Text] [Related]
15. Valuation of exfoliative cytology as prediction factor in oral mucosa lesions.
Brunotto M; Zárate AM; Cismondi A; Fernández Mdel C; Noher de Halac RI
Med Oral Patol Oral Cir Bucal; 2005 Jul; 10 Suppl 2():E92-102. PubMed ID: 15995578
[TBL] [Abstract][Full Text] [Related]
16. Expression of survivin and XIAP for DMBA-induced hamster buccal pouch squamous cell carcinogenesis is associated with p53 accumulation.
Hsue SS; Chen YK; Lin LM
Oral Oncol; 2008 Jan; 44(1):43-9. PubMed ID: 17306609
[TBL] [Abstract][Full Text] [Related]
17. H-ras and c-fos exhibit similar expression patterns during most stages of oral oncogenesis.
Vairaktaris E; Papakosta V; Derka S; Vassiliou S; Nkenke E; Spyridonidou S; Vylliotis A; Lazaris A; Kokkori A; Moulavassili P; Loukeri S; Perrea D; Donta I; Yapijakis C; Patsouris E
In Vivo; 2008; 22(5):621-8. PubMed ID: 18853758
[TBL] [Abstract][Full Text] [Related]
18. Diabetes may increase risk for oral cancer through the insulin receptor substrate-1 and focal adhesion kinase pathway.
Goutzanis L; Vairaktaris E; Yapijakis C; Kavantzas N; Nkenke E; Derka S; Vassiliou S; Acil Y; Kessler P; Stavrianeas N; Perrea D; Donta I; Skandalakis P; Patsouris E
Oral Oncol; 2007 Feb; 43(2):165-73. PubMed ID: 16860589
[TBL] [Abstract][Full Text] [Related]
19. Creating oral squamous cancer cells: a cellular model of oral-esophageal carcinogenesis.
Goessel G; Quante M; Hahn WC; Harada H; Heeg S; Suliman Y; Doebele M; von Werder A; Fulda C; Nakagawa H; Rustgi AK; Blum HE; Opitz OG
Proc Natl Acad Sci U S A; 2005 Oct; 102(43):15599-604. PubMed ID: 16239349
[TBL] [Abstract][Full Text] [Related]
20. Assessment of p53 protein expression in normal, benign, and malignant oral mucosa.
Ogden GR; Kiddie RA; Lunny DP; Lane DP
J Pathol; 1992 Apr; 166(4):389-94. PubMed ID: 1381431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
